• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物活性硅酸三钙的牙本质替代物作为乳牙间接盖髓材料的12个月随访

Bioactive Tricalcium Silicate-based Dentin Substitute as an Indirect Pulp Capping Material for Primary Teeth: A 12-month Follow-up.

作者信息

Garrocho-Rangel Arturo, Quintana-Guevara Karina, Vázquez-Viera Rocío, Arvizu-Rivera Juana María, Flores-Reyes Héctor, Escobar-García Diana María, Pozos-Guillén Amaury

机构信息

Associate professor, in the Pediatric Dentistry Postgraduate Program, in the Faculty of Dentistry, San Luis Potosi University, San Luis Potosí, SLP, México.

Resident, in the Pediatric Dentistry Postgraduate Program, in the Faculty of Dentistry, San Luis Potosi University, San Luis Potosí, SLP, México.

出版信息

Pediatr Dent. 2017 Sep 15;39(5):377-382.

PMID:29070160
Abstract

PURPOSE

The purpose of this study was to evaluate the clinical and radiographic outcomes of a bioactive tricalcium silicate [Ca3SiO5]-based dentin substitute and a light-activated calcium hydroxide [Ca(OH)2]-based liner as indirect pulp treatment (IPT) interventions for vital primary molars with carious lesions approaching the pulp.

METHODS

Eighty children, aged four to eight years old, with 160 bilateral primary teeth without signs or symptoms of irreversibly inflamed or degenerative pulp tissue were treated in a split-mouth design trial comparing IPT using Ca3SiO5 or Ca(OH)2. The teeth were treated and restored with a preformed crown in a single session and assessed clinically and radiographically for one, three, six, and 12 months.

RESULTS

Sixty patients with 120 treated molars completed the 12-month evaluations. The combined clinical and radiographic success rates were 98.3 percent (59 out of 60) for Ca3SiO5 and 95 percent for Ca(OH)2 (57 out of 60). No significant differences were found for success rates between the two study groups (P>0.05). The combined success rates for both groups was 96.7 percent.

CONCLUSIONS

These results suggest that the indirect pulp treatment procedure with either a bioactive Ca3SiO5-based dentin substitute or a Ca(OH)2-based material may be considered a suitable treatment to achieve acceptable therapeutic results when applied on deeply carious primary teeth without degenerative symptoms.

摘要

目的

本研究旨在评估一种基于生物活性硅酸三钙[Ca3SiO5]的牙本质替代物和一种基于光活化氢氧化钙[Ca(OH)2]的垫底材料作为间接盖髓治疗(IPT)干预措施,用于治疗龋损接近牙髓的活髓乳磨牙的临床和影像学结果。

方法

80名4至8岁的儿童,共160颗双侧乳牙,无不可逆性炎症或牙髓组织退变的体征或症状,采用分口设计试验进行治疗,比较使用Ca3SiO5或Ca(OH)2进行间接盖髓治疗的效果。牙齿在单次就诊时进行治疗并使用预成冠修复,并在1、3、6和12个月时进行临床和影像学评估。

结果

60名患者的120颗治疗磨牙完成了12个月的评估。Ca3SiO5组的临床和影像学综合成功率为98.3%(60颗中的59颗),Ca(OH)2组为95%(60颗中的57颗)。两个研究组之间的成功率无显著差异(P>0.05)。两组的综合成功率为96.7%。

结论

这些结果表明,当应用于无退变症状的深龋乳牙时,使用基于生物活性Ca3SiO5的牙本质替代物或基于Ca(OH)2的材料进行间接盖髓治疗可能被认为是一种合适的治疗方法,可取得可接受的治疗效果。

相似文献

1
Bioactive Tricalcium Silicate-based Dentin Substitute as an Indirect Pulp Capping Material for Primary Teeth: A 12-month Follow-up.基于生物活性硅酸三钙的牙本质替代物作为乳牙间接盖髓材料的12个月随访
Pediatr Dent. 2017 Sep 15;39(5):377-382.
2
Clinical, radiographic, and histological evaluation of three different pulp-capping materials in indirect pulp treatment of primary teeth: a randomized clinical trial.临床、放射学和组织学评价三种不同盖髓材料在乳前牙间接盖髓治疗中的应用:一项随机临床试验。
Clin Oral Investig. 2021 Jun;25(6):3945-3955. doi: 10.1007/s00784-020-03724-4. Epub 2021 Jan 6.
3
Evaluation of indirect pulp capping using three different materials: A randomized control trial using cone-beam computed tomography.使用三种不同材料进行间接盖髓术的评估:一项使用锥形束计算机断层扫描的随机对照试验。
Indian J Dent Res. 2016 Nov-Dec;27(6):623-629. doi: 10.4103/0970-9290.199588.
4
Comparative evaluation of biodentine, 2% chlorhexidine with RMGIC and calcium hydroxide as indirect pulp capping materials in primary molars: An study.生物活性玻璃陶瓷、含2%氯己定的树脂改性玻璃离子水门汀和氢氧化钙作为乳磨牙间接盖髓材料的比较评价:一项研究。
J Indian Soc Pedod Prev Dent. 2019 Jan-Mar;37(1):60-66. doi: 10.4103/JISPPD.JISPPD_213_17.
5
Evaluation of Radiological Outcomes of Theracal Light Cured (TLC) And Calcium Hydroxide As Indirect Pulp Capping Agents In The Treatment Of Deep Carious Lesion Of Permanent Molar Teeth.评估Theracal光固化材料(TLC)和氢氧化钙作为间接盖髓剂治疗恒牙深龋病变的放射学结果。
Mymensingh Med J. 2018 Oct;27(4):859-865.
6
Is Bioactive Glass an Effective Agent in Pulp-capping Treatments?: A Randomized Controlled Clinical Trial with One-year Follow-up.生物活性玻璃在盖髓治疗中是否有效?:一项为期一年随访的随机对照临床试验。
J Contemp Dent Pract. 2022 Nov 1;23(11):1128-1135. doi: 10.5005/jp-journals-10024-3428.
7
Comparative Evaluation of Indirect Pulp Therapy in Young Permanent Teeth using Biodentine and Theracal: A Randomized Clinical Trial.使用 Biodentine 和 Theracal 对年轻恒牙进行间接牙髓治疗的对比评估:一项随机临床试验。
J Clin Pediatr Dent. 2021 Jul 1;45(3):158-164. doi: 10.17796/1053-4625-45.3.3.
8
Evaluation of four vital pulp therapies for primary molars using a dual-cured tricalcium silicate (TheraCal PT): one-year results of a non-randomized clinical trial.采用双固化硅酸三钙(TheraCal PT)对乳磨牙的四种活髓治疗方法的评价:一项非随机临床试验的一年结果。
J Clin Pediatr Dent. 2023 Mar;47(2):10-22. doi: 10.22514/jocpd.2023.004. Epub 2023 Mar 3.
9
Pulp management after traumatic injuries with a tricalcium silicate-based cement (Biodentine™): a report of two cases, up to 48 months follow-up.使用硅酸三钙基水门汀(Biodentine™)处理创伤性损伤后的牙髓管理:两例报告及长达48个月的随访
Eur Arch Paediatr Dent. 2015 Dec;16(6):491-6. doi: 10.1007/s40368-015-0191-y. Epub 2015 May 31.
10
Prognostic factors in direct pulp capping with mineral trioxide aggregate or calcium hydroxide: 2- to 6-year follow-up.使用三氧化矿物凝聚体或氢氧化钙进行直接盖髓术的预后因素:2至6年随访
Clin Oral Investig. 2017 Jan;21(1):357-367. doi: 10.1007/s00784-016-1798-z. Epub 2016 Apr 4.

引用本文的文献

1
Clinical and radiographic success of pulpotomy and pulpectomy in primary and permanent teeth: a Systematic Review and Meta-Analysis.乳牙和恒牙活髓切断术与根管治疗术的临床及影像学成功率:一项系统评价与Meta分析
J Clin Exp Dent. 2024 Sep 1;16(9):e1120-e1128. doi: 10.4317/jced.61346. eCollection 2024 Sep.
2
Comparative Clinical and Radiographic Success Rate of Bioceramic Premix vs Biosilicate-based Medicament as Indirect Pulp Treatment Materials in Primary Molars: A Double-blind Randomized Trial with a Follow-up of 12 Months.生物陶瓷预混剂与生物硅基药物作为乳磨牙间接盖髓治疗材料的临床和影像学成功率比较:一项为期12个月随访的双盲随机试验
Int J Clin Pediatr Dent. 2024 Jul;17(7):748-753. doi: 10.5005/jp-journals-10005-2871.
3
Traditional Versus Advanced Pulp Capping Materials in Primary Teeth.
传统与先进的乳牙盖髓材料。
Ann Afr Med. 2024 Jul 1;23(3):243-247. doi: 10.4103/aam.aam_66_23. Epub 2024 Jul 20.
4
Silver Diamine Fluoride as a Medicament for the Indirect Pulp Therapy in Primary Teeth: A Review of the Literature.氟化亚锡作为乳牙间接盖髓治疗药物的文献综述
Cureus. 2024 May 21;16(5):e60780. doi: 10.7759/cureus.60780. eCollection 2024 May.
5
Recent Advances in Indirect Pulp Treatment Materials for Primary Teeth: A Literature Review.乳牙间接盖髓治疗材料的最新进展:文献综述
Int J Clin Pediatr Dent. 2021 Nov-Dec;14(6):795-801. doi: 10.5005/jp-journals-10005-2073.
6
Association of Vital Pulp Therapy Outcomes with Tooth Type, Arch Location, Treatment Type, and Number of Surfaces Destroyed in Deciduous Teeth: A Retrospective Study.恒牙活髓治疗预后与牙位、牙弓位置、治疗类型以及乳磨牙破坏牙面数的相关性:一项回顾性研究。
Int J Environ Res Public Health. 2021 Jul 28;18(15):7970. doi: 10.3390/ijerph18157970.
7
Clinical, radiographic, and histological evaluation of three different pulp-capping materials in indirect pulp treatment of primary teeth: a randomized clinical trial.临床、放射学和组织学评价三种不同盖髓材料在乳前牙间接盖髓治疗中的应用:一项随机临床试验。
Clin Oral Investig. 2021 Jun;25(6):3945-3955. doi: 10.1007/s00784-020-03724-4. Epub 2021 Jan 6.
8
Clinical and Radiographic Outcomes of Calcium Hydroxide vs Other Agents in Indirect Pulp Capping of Primary Teeth: A Systematic Review.氢氧化钙与其他药物用于乳牙间接盖髓术的临床和影像学结果:一项系统评价
Int J Clin Pediatr Dent. 2019 Sep-Oct;12(5):437-444. doi: 10.5005/jp-journals-10005-1672.
9
Remineralization ability of two hydraulic calcium-silicate based dental pulp capping materials: Cell-independent model.两种水硬性硅酸钙基牙髓盖髓材料的再矿化能力:非细胞模型
J Clin Exp Dent. 2019 Apr 1;11(4):e360-e366. doi: 10.4317/jced.55689. eCollection 2019 Apr.